Literature DB >> 27479284

Variable-number tandem-repeat analysis of leptospiral DNA isolated from canine urine samples molecularly confirmed to contain pathogenic leptospires.

Kenneth R Harkin, Michael P Hays.   

Abstract

OBJECTIVE To use variable-number tandem-repeat (VNTR) analysis to determine the infecting serovar and strain for leptospiral DNA isolated from canine urine samples confirmed through PCR testing to contain pathogenic leptospires and to evaluate the sensitivity and specificity of microscopic agglutination testing (MAT) for identifying the infecting serogroup. DESIGN Diagnostic survey and test evaluation. SAMPLE Leptospiral DNA isolated from urine samples from 98 dogs confirmed through PCR testing to have pathogenic leptospires in their urine. PROCEDURES VNTR analysis of DNA isolates was performed to identify the infecting leptospiral serovar and strain by use of primer pairs for the loci 4, 7, 10, and Lb5. Eighteen pathogenic and 2 saprophytic leptospiral serovars were used as reference strains for VNTR analysis. Results of MAT were compared with those of the PCR assay and VNTR analysis to determine the sensitivity and specificity of MAT for diagnosing leptospirosis and identifying the infecting serovar at various reciprocal titers. RESULTS VNTR analysis identified Leptospira kirschneri serovar Grippotyphosa strain DF as the most common infecting serovar in dogs (78/98 [80%]). Thirteen unique VNTR patterns could not be identified by comparison with the Leptospira reference strains used. The MAT had a maximum sensitivity of 41% and a specificity of 100% for identifying Grippotyphosa as the infecting serogroup. CONCLUSIONS AND CLINICAL RELEVANCE Findings confirmed the importance of Leptospira serovar Grippotyphosa among dogs in the United States. Serologic testing had poor sensitivity for identifying the infecting serogroup, and conclusions about emerging serogroups should be cautiously interpreted when serologic data are reported.

Entities:  

Mesh:

Year:  2016        PMID: 27479284     DOI: 10.2460/javma.249.4.399

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

Review 1.  Role of Diagnostics in Epidemiology, Management, Surveillance, and Control of Leptospirosis.

Authors:  Jane E Sykes; Krystle L Reagan; Jarlath E Nally; Renee L Galloway; David A Haake
Journal:  Pathogens       Date:  2022-03-24

2.  Clinical, diagnostic, and epidemiological features of a community-wide outbreak of canine leptospirosis in a low-prevalence region (Maricopa County, Arizona).

Authors:  Sally Ann Iverson; Craig Levy; Hayley D Yaglom; Heather L Venkat; Aileen Artus; Renee Galloway; Sarah Anne J Guagliardo; Laura Reynolds; Melissa JoAnne Kretschmer; Margaret E LaFerla Jenni; Peter Woodward; Alison A Reindel; Sheena Tarrant; Tammy Sylvester; Ronald Klein; Peter Mundschenk; Rebecca Sunenshine; Ilana J Schafer
Journal:  J Am Vet Med Assoc       Date:  2021-03-15       Impact factor: 1.936

3.  Detection and characterization of Leptospira spp. in dogs diagnosed with kidney and/or liver disease in Selangor, Malaysia.

Authors:  Sabri A Rahman; Kuan H Khor; Siti Khairani-Bejo; Seng F Lau; Mazlina Mazlan; Azri Roslan; Soon H Goh
Journal:  J Vet Diagn Invest       Date:  2021-06-19       Impact factor: 1.569

4.  Prospective study of canine leptospirosis in shelter and stray dog populations: Identification of chronic carriers and different Leptospira species infecting dogs.

Authors:  Bruno Alonso Miotto; Aline Gil Alves Guilloux; Barbara Furlan Tozzi; Luisa Zanolli Moreno; Aline Santana da Hora; Ricardo Augusto Dias; Marcos Bryan Heinemann; Andrea Micke Moreno; Antônio Francisco de Souza Filho; Walter Lilenbaum; Mitika Kuribayashi Hagiwara
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

5.  Seroprevalence, frequency of leptospiuria, and associated risk factors in horses in Kansas, Missouri, and Nebraska from 2016-2017.

Authors:  Amanda C Trimble; Christopher A Blevins; Laurie A Beard; Ashley R Deforno; Elizabeth G Davis
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.